Diabetes Market May Top $1 Bil. With Stick Replacement Claim – Abbott
This article was originally published in The Gray Sheet
Executive Summary
Abbott Labs expects its Freestyle Navigator to be the first continuous blood glucose monitor approved in the U.S. as a replacement for traditional fingerstick tests